Deprecated: The each() function is deprecated. This message will be suppressed on further calls in /home/zhenxiangba/zhenxiangba.com/public_html/phproxy-improved-master/index.php on line 456
JP7630764B2 - Hair Anti-Aging Agent - Google Patents
[go: Go Back, main page]

JP7630764B2 - Hair Anti-Aging Agent - Google Patents

Hair Anti-Aging Agent Download PDF

Info

Publication number
JP7630764B2
JP7630764B2 JP2020101481A JP2020101481A JP7630764B2 JP 7630764 B2 JP7630764 B2 JP 7630764B2 JP 2020101481 A JP2020101481 A JP 2020101481A JP 2020101481 A JP2020101481 A JP 2020101481A JP 7630764 B2 JP7630764 B2 JP 7630764B2
Authority
JP
Japan
Prior art keywords
hair
stem cells
improving
cells
agent
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
JP2020101481A
Other languages
Japanese (ja)
Other versions
JP2021004235A (en
Inventor
良平 新井
優治 谷
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Taisho Pharmaceutical Co Ltd
Original Assignee
Taisho Pharmaceutical Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Taisho Pharmaceutical Co Ltd filed Critical Taisho Pharmaceutical Co Ltd
Publication of JP2021004235A publication Critical patent/JP2021004235A/en
Application granted granted Critical
Publication of JP7630764B2 publication Critical patent/JP7630764B2/en
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Landscapes

  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Cosmetics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Description

本発明は、白髪又は老人性脱毛症の予防又は改善剤、毛包構成細胞のDNA損傷抑制又は改善剤、及び、色素幹細胞の減少抑制剤に関する。 The present invention relates to an agent for preventing or improving gray hair or senile alopecia, an agent for suppressing or improving DNA damage in hair follicle constituent cells, and an agent for suppressing the decrease in melanocyte stem cells.

体毛の色素(メラニン)は毛球部に存在する色素細胞により産生され、この色素を供給された上皮細胞が体毛を形成することにより、有色毛が発生する。体毛が生え変わる際に毛球部は消失し、それに伴って毛球部の色素細胞も消失する。毛包中のバルジ領域と呼ばれる部分には毛包幹細胞と色素幹細胞が存在しており、新たな毛周期が始まり新たな体毛が生じる際には、毛包幹細胞から上皮細胞が色素幹細胞から色素細胞がそれぞれ毛球部へ供給され、再び上記のサイクルが繰り返される。 The pigment (melanin) in hair is produced by pigment cells present in the hair bulb, and epithelial cells that are supplied with this pigment form hair, resulting in the development of colored hair. When hair falls out and is replaced, the hair bulb disappears, and with it the pigment cells in the hair bulb. Hair follicle stem cells and melanocyte stem cells reside in a part of the hair follicle called the bulge region, and when a new hair cycle begins and new hair is produced, the hair follicle stem cells supply epithelial cells to the hair bulb, and the melanocyte stem cells supply melanocytes to the hair bulb, and the cycle above is repeated once again.

白髪の発生原因は、加齢・ストレス・白斑に伴うもの等いくつかあり、上述の過程の一部に異常が生じることにより生じる。過去には、毛球部の色素細胞の色素産生能を維持又は改善することで、白髪を予防または改善することができると信じられ、色素細胞内で色素合成に関わるチロシナーゼをはじめとする酵素を活性化する作用を指標として、数多くの物質が見出されている(特許文献1~5)。 There are several causes of gray hair, including aging, stress, and vitiligo, and it occurs when an abnormality occurs in one of the above-mentioned processes. In the past, it was believed that gray hair could be prevented or improved by maintaining or improving the pigment production ability of the pigment cells in the hair bulb, and many substances were discovered that activate enzymes such as tyrosinase, which is involved in pigment synthesis in pigment cells (Patent Documents 1 to 5).

近年、加齢による白髪発生のメカニズムが解明された。修復不可能な程度のDNA損傷が蓄積した色素幹細胞は、バルジ領域にいながら分化して(この分化を異所性分化という)、自己維持機能を失い消失する(非特許文献1)。その結果、毛球部に色素細胞が供給できず、色素を持たない上皮細胞が毛を作ることで白髪が生じる。つまり加齢による白髪の大部分では、そもそも毛球部に色素細胞が存在しておらず、色素合成に関わる酵素の活性化では改善できない。毛球部に色素細胞が残存している白髪は旧来のアプローチで改善可能と考えられるが、白髪(加齢によるものとは限らない)のうち、毛球部に色素細胞が存在するものはわずか20%程度との調査結果がある(非特許文献2)。 In recent years, the mechanism of hair graying due to aging has been elucidated. Melanocyte stem cells that have accumulated DNA damage to an extent that cannot be repaired differentiate while still in the bulge region (this differentiation is called ectopic differentiation), lose their self-maintenance function, and disappear (Non-Patent Document 1). As a result, pigment cells cannot be supplied to the hair bulb, and epithelial cells that do not have pigment produce hair, resulting in gray hair. In other words, in the majority of gray hair caused by aging, there are no pigment cells in the hair bulb to begin with, and activation of enzymes involved in pigment synthesis cannot improve the condition. Gray hair with pigment cells remaining in the hair bulb is thought to be able to be improved with traditional approaches, but survey results show that only about 20% of gray hair (not necessarily caused by aging) has pigment cells in the hair bulb (Non-Patent Document 2).

また、さらに色素幹細胞は毛包幹細胞の働きによって維持されていることが解明された(非特許文献3)。毛包幹細胞は、TGF-βやWNTリガンドをはじめとする因子を産生することにより、色素幹細胞が幹細胞性を保ったままで存在できる環境(色素幹細胞ニッチ)を構成し、色素幹細胞の維持・活性化を制御している(非特許文献3,4)。つまり白髪を予防又は改善するためには、毛包幹細胞を維持し、さらにその色素幹細胞ニッチ機能を維持することにより、色素幹細胞の消失を防ぐことが重要である。 It has also been elucidated that melanocyte stem cells are maintained by the function of hair follicle stem cells (Non-Patent Document 3). Hair follicle stem cells produce factors including TGF-β and WNT ligands, creating an environment (melanocyte stem cell niche) in which melanocyte stem cells can exist while maintaining their stemness, and controlling the maintenance and activation of melanocyte stem cells (Non-Patent Documents 3, 4). In other words, in order to prevent or improve gray hair, it is important to maintain hair follicle stem cells and further maintain the melanocyte stem cell niche function to prevent the disappearance of melanocyte stem cells.

黒色マウスにX線を用いてDNA損傷を与えることで、上述の加齢による機序を反映した白毛を誘導できることが知られており、広く加齢性マウス白髪モデルとして用いられている(特許文献6)。また、本モデルにおいてX線は、毛包幹細胞と色素幹細胞の両方に損傷を与えるが、その主要な標的は毛包幹細胞(色素幹細胞ニッチ機能の障害)であることが解明されている(非特許文献5)。 It is known that by inflicting DNA damage in black mice using X-rays, it is possible to induce gray hair that reflects the above-mentioned age-related mechanisms, and this is widely used as an age-related mouse gray hair model (Patent Document 6). In this model, X-rays damage both hair follicle stem cells and melanocyte stem cells, but it has been elucidated that the primary target is hair follicle stem cells (impairment of melanocyte stem cell niche function) (Non-Patent Document 5).

特開2001-288052号公報JP 2001-288052 A 特開2001-131032号公報JP 2001-131032 A 特開2007-8888号公報JP 2007-8888 A 特開2011-157317号公報JP 2011-157317 A 特開2002-47130号公報JP 2002-47130 A 特開2015-193550号公報JP 2015-193550 A

Inomata K, Aoto T, Binh NT, Okamoto N, Tanimura S, Wakayama T, Iseki S, Hara E, Masunaga T, Shimizu H, Nishimura EK, Genotoxic stress abrogates renewal of melanocyte stem cells by triggering their differentiation, Cell.2009;137(6):1088-99.Inomata K, Aoto T, Binh NT, Okamoto N, Tanimura S, Wakayama T, Iseki S, Hara E, Masunaga T, Shimizu H, Nishimura EK, Genotoxic stress abrogates renewal of melanocyte stem cells by triggering their differentiation, Cell.2009;137(6):1088-99. 出田立郎ら著「アンチエイジングシリーズ1 白髪・脱毛・育毛の実際」エヌ・ティー・エス、2005年7月4日、p.49-61"Anti-aging Series 1: The reality of gray hair, hair loss, and hair growth," by Tatsuro Ideta et al., NTS, July 4, 2005, p.49-61 Tanimura S, Tadokoro Y, Inomata K, Binh NT, Nishie W, Yamazaki S, Nakauchi H, Tanaka Y, McMillan JR, Sawamura D, Yancey K, Shimizu H, Nishimura EK, Hair follicle stem cells provide a functional niche for melanocyte stem cells, Cell Stem Cell. 2011;8(2):177-87.Tanimura S, Tadokoro Y, Inomata K, Binh NT, Nishie W, Yamazaki S, Nakauchi H, Tanaka Y, McMillan JR, Sawamura D, Yancey K, Shimizu H, Nishimura EK, Hair follicle stem cells provide a functional niche for melanocyte stem cells, Cell Stem Cell. 2011;8(2):177-87. Rabbani P, Takeo M Chou W, Myung P, Bosenberg M, Chin L, Taketo MM, Ito M, Coordinated activation of Wnt in epithelial and melanocyte stem cells initiates pigmented hair regeneration, Cell. 2011 Jun 10;145(6):941-955.Rabbani P, Takeo M Chou W, Myung P, Bosenberg M, Chin L, Taketo MM, Ito M, Coordinated activation of Wnt in epithelial and melanocyte stem cells initiates pigmented hair regeneration, Cell. 2011 Jun 10;145(6):941-955. Aoki H, Hara A, Motohashi T, Kunisada T, Keratinocyte stem cells but not melanocyte stem cells are the primary target for radiation-induced hair graying, J Invest Dermatol. 2013;133(9):2143-51.Aoki H, Hara A, Motohashi T, Kunisada T, Keratinocyte stem cells but not melanocyte stem cells are the primary target for radiation-induced hair graying, J Invest Dermatol. 2013;133(9):2143-51. Matsumura H, Mohri Y, Binh NT, Morinaga H, Fukuda M, Ito M, Kurata S, Hoeijmakers J, Nishimura EK, Hair follicle aging is driven by transepidermal elimination of stem cells via COL17A1 proteolysis, Science. 2016;351(6273):aad4395.Matsumura H, Mohri Y, Binh NT, Morinaga H, Fukuda M, Ito M, Kurata S, Hoeijmakers J, Nishimura EK, Hair follicle aging is driven by transepidermal elimination of stem cells via COL17A1 proteolysis, Science. 2016;351(6273):aad4395.

本発明の目的は、白髪を予防又は改善する手段を提供することである。また、加齢により生じる脱毛を予防又は改善する手段を提供することである。また、毛包構成細胞のDNA損傷抑制又は改善剤を提供することである。また、色素幹細胞の減少抑制剤を提供することである。 The object of the present invention is to provide a means for preventing or improving gray hair. It is also to provide a means for preventing or improving hair loss caused by aging. It is also to provide an agent for suppressing or improving DNA damage in hair follicle constituent cells. It is also to provide an agent for suppressing the decrease in melanocyte stem cells.

そこで発明者らは鋭意検討した結果、ベルベルビン及びその誘導体、さらにこれらの塩が、優れた白髪又は老人性脱毛の予防又は改善作用を有すると共に、その作用が毛包構成細胞のDNA損傷抑制又は改善作用、及び色素幹細胞の減少抑制作用に起因することを解明し、本発明を完成するに至った。 As a result of intensive research, the inventors have discovered that berberrubine and its derivatives, as well as salts thereof, have excellent preventive or ameliorative effects on gray hair or age-related alopecia, and that these effects are attributable to their suppression or amelioration of DNA damage in hair follicle constituent cells and their suppression of the decline in melanocyte stem cells, thus completing the present invention.

すなわち、本発明は、
(1)ベルベルビン、その誘導体(ただし、ベルベリンを除く)、及びこれらの塩からなる群から選択される少なくとも1種を有効成分とする、白髪の予防又は改善剤、
(2)ベルベルビン、その誘導体、及びこれらの塩からなる群から選択される少なくとも1種を有効成分とする、老人性脱毛症の予防又は改善剤、
(3)ベルベルビン、その誘導体、及びこれらの塩からなる群から選択される少なくとも1種を有効成分とする、毛包構成細胞のDNA損傷抑制又は改善剤、
(4)毛包構成細胞が、毛包幹細胞又は色素幹細胞である、(3)に記載のDNA損傷抑制又は改善剤、
(5)ベルベルビン、その誘導体、及びこれらの塩からなる群から選択される少なくとも1種を有効成分とする、色素幹細胞の減少抑制剤、
である。
That is, the present invention provides
(1) An agent for preventing or improving gray hair, comprising at least one active ingredient selected from the group consisting of berberrubine, its derivatives (excluding berberine), and salts thereof;
(2) An agent for preventing or improving senile alopecia, comprising as an active ingredient at least one selected from the group consisting of berberrubine, its derivatives, and salts thereof;
(3) An agent for suppressing or improving DNA damage in hair follicle constituent cells, comprising at least one active ingredient selected from the group consisting of berberrubine, its derivatives, and salts thereof;
(4) The agent for suppressing or ameliorating DNA damage according to (3), wherein the hair follicle-constituting cells are hair follicle stem cells or melanocyte stem cells.
(5) An agent for suppressing a decrease in pigment stem cells, comprising at least one active ingredient selected from the group consisting of berberrubine, its derivatives, and salts thereof.
It is.

本発明の白髪及び脱毛の予防又は改善剤は、毛包構成細胞のDNA損傷抑制又は改善作用又は色素幹細胞の減少抑制作用を介して、白髪及び老人性脱毛の発生を予防し又は改善することができる。 The agent for preventing or improving gray hair and hair loss of the present invention can prevent or improve the occurrence of gray hair and age-related hair loss by suppressing or improving DNA damage in hair follicle constituent cells or by suppressing the decrease in melanocyte stem cells.

図1は、試験例1において、ベルベルビンを評価した際の、マウスの背部体毛明度を示すグラフである。FIG. 1 is a graph showing the lightness of mouse back hair when berberrubine was evaluated in Test Example 1. 図2は、試験例1において、ベルベリンを評価した際の、マウスの背部体毛明度を示すグラフである。FIG. 2 is a graph showing the lightness of mouse back hair when berberine was evaluated in Test Example 1. 図3は、試験例2において、ベルベリンを評価した際の、除毛後15日目におけるマウスの発毛スコアを示すグラフである。FIG. 3 is a graph showing the hair growth score of mice 15 days after hair removal when evaluating berberine in Test Example 2. 図4は、試験例2において、ベルベリンを評価した際の、除毛後17日目におけるマウスの発毛スコアを示すグラフである。FIG. 4 is a graph showing the hair growth score of mice 17 days after hair removal when evaluating berberine in Test Example 2.

本発明におけるベルベルビンとは、5,6-ジヒドロ-9-ヒドロキシ-10-メトキシベンゾ[g]-1,3-ベンゾジオキソロ[5,6-a]キノリジニウムで表される化合物である。
本発明における誘導体とは、もとの化合物の分子内の小部分を変化させて得られる化合物のことである。特に限定されるものではないが例えば、ベルベルビンのヒドロキシ基の一つがメトキシ基に変化したベルベリン(2,3-メチレンジオキシ-9,10-ジメトキシ-5,6-ジヒドロジベンゾ[a,g]キノリジニウム)が挙げられる。
本発明における塩とは、例えば塩化物、塩酸、硫酸やタンニン酸との塩が挙げられるが、特に限定されるものではない。
Berberrubin in the present invention is a compound represented by 5,6-dihydro-9-hydroxy-10-methoxybenzo[g]-1,3-benzodioxolo[5,6-a]quinolizinium.
The derivative in the present invention refers to a compound obtained by changing a small part in the molecule of the original compound. An example of a derivative is, but is not limited to, berberine (2,3-methylenedioxy-9,10-dimethoxy-5,6-dihydrodibenzo[a,g]quinolizinium), in which one of the hydroxyl groups of berberrubine is changed to a methoxy group.
The salt in the present invention includes, but is not limited to, for example, chlorides, salts with hydrochloric acid, sulfuric acid, and tannic acid.

本発明に用いるベルべルビン、その誘導体、及びそれらの塩は、既知の合成法で製造可能であり、また市販品を用いてもよい。市販品としては、塩化ベルベルビン(長良サイエンス株式会社製、キシダ化学株式会社製)、塩化ベルベリン(Sigma-Aldrich製)、ベルベリン塩酸塩(ナカライテスク製)、ベルベリン塩化物水和物(アルプス薬品工業製)、タンニン酸ベルベリン(アルプス薬品工業製)等が挙げられる。 Berberbine, its derivatives, and their salts used in the present invention can be produced by known synthesis methods, or commercially available products may be used. Commercially available products include berberbine chloride (manufactured by Nagara Science Co., Ltd. and Kishida Chemical Co., Ltd.), berberine chloride (manufactured by Sigma-Aldrich), berberine hydrochloride (manufactured by Nacalai Tesque), berberine chloride hydrate (manufactured by Alps Pharmaceutical Co., Ltd.), and berberine tannate (manufactured by Alps Pharmaceutical Co., Ltd.).

本発明における毛包構成細胞とは、毛包組織を構成するあらゆる細胞を示す。例えば、上皮系細胞である、毛包幹細胞、外毛根鞘細胞、内毛根鞘細胞及び毛母細胞、色素系細胞である、色素幹細胞、色素芽細胞及び色素細胞、並びに、間葉系細胞である、毛乳頭細胞及び真皮毛根鞘細胞がある。 In the present invention, hair follicle-constituting cells refer to any cell that constitutes hair follicle tissue. Examples include epithelial cells such as hair follicle stem cells, outer root sheath cells, inner root sheath cells, and hair matrix cells, pigment cells such as melanocyte stem cells, chromatoblasts, and pigment cells, and mesenchymal cells such as hair papilla cells and dermal root sheath cells.

本発明における毛包幹細胞とは、毛包のバルジ領域及び二次毛芽に存在する、上皮系細胞の幹細胞をいう。 In the present invention, hair follicle stem cells refer to epithelial cell stem cells that exist in the bulge region of the hair follicle and in the secondary hair germ.

本発明における色素幹細胞とは、毛包のバルジ領域及び二次毛芽に存在する、色素系細胞の幹細胞をいう。 In the present invention, melanocyte stem cells refer to stem cells of pigment cells that exist in the bulge region of the hair follicle and in the secondary hair germ.

また、本発明の白髪及び老人性脱毛の予防又は改善作用は、上皮系細胞の色素系細胞に対するニッチ機能の維持又は改善作用、色素幹細胞の異所性分化抑制作用、並びに、毛包幹細胞及び色素幹細胞の減少抑制作用に起因すると考えられる。異所性分化とは、色素幹細胞が本来は幹細胞として存在すべき毛包バルジ領域にいながら、色素細胞へ分化する現象をいう。また、ニッチ機能とは、ある種の細胞が他の細胞の存在する環境を構築し、制御する機能をいう。 The preventive or ameliorative effects of the present invention on gray hair and age-related alopecia are believed to be due to the effect of maintaining or improving the niche function of epithelial cells on pigment cells, the effect of inhibiting ectopic differentiation of melanocyte stem cells, and the effect of inhibiting the decline of hair follicle stem cells and melanocyte stem cells. Ectopic differentiation refers to the phenomenon in which melanocyte stem cells differentiate into melanocytes while remaining in the hair follicle bulge region where they should normally exist as stem cells. Niche function refers to the function of certain cells to create and control the environment in which other cells exist.

本発明の白髪予防又は改善剤は、医薬部外品、医薬品又は飲食品等として提供することができる。その他、試薬(陽性対照等)として用いることも可能である。投与形態としては、特に限定されるものではないが、外用や内服が挙げられ、好ましくは頭皮を含む皮膚に適用する外用である。 The agent for preventing or improving gray hair of the present invention can be provided as a quasi-drug, medicine, food or drink, etc. It can also be used as a reagent (positive control, etc.). The form of administration is not particularly limited, but examples include external application and internal administration, and is preferably external application to the skin including the scalp.

本発明を外用で適用する場合の剤形としては、例えば、ローション剤、液剤、クリーム剤、軟膏剤、ゲル剤、スプレー剤、シャンプー、コンディショナー、石鹸等が挙げられ、内服で適用する場合の剤形としては、錠剤、粉末剤、散剤、顆粒剤、液剤、カプセル剤、ドライシロップ剤、ゼリー剤、液状食品、半固形食品、固形食品等が挙げられる。
これらは、公知の方法で製造することができる。製造に際しては、本発明の効果を損なわない範囲で、化粧品、医薬部外品、医薬品、飲食品又は試薬に含有可能な種々の添加物を配合することができる。
When the present invention is applied externally, examples of the dosage form include lotions, liquids, creams, ointments, gels, sprays, shampoos, conditioners, soaps, etc., and when the present invention is applied internally, examples of the dosage form include tablets, powders, granules, liquids, capsules, dry syrups, jellies, liquid foods, semi-solid foods, solid foods, etc.
These can be produced by known methods. During production, various additives that can be contained in cosmetics, quasi-drugs, medicines, foods and beverages, or reagents can be blended within the range that does not impair the effects of the present invention.

さらに本発明の白髪予防又は改善剤は、センブリエキス、ニンジンエキス、トウガラシチンキ、ショウキョウチンキ、ビワ葉エキス、グリチルレチン酸、グリチルリチン酸ジカリウム、グリチルリチン酸モノアンモニウム、パントテン酸、パンテノール、ビタミンE及びその誘導体、ヒノキチオール、サリチル酸、ピロクトンオラミン、ミノキシジル、アデノシン、t-フラバノン、サイトプリン、ペンタデカン酸グリセリド、アラントイン、ニコチン酸アミドをはじめとした発育毛物質と組み合わせて使用することもできる。組み合わせることにより、毛の産生が早まり、早期に白髪予防又は改善効果を得ることができる。 Furthermore, the agent for preventing or improving gray hair of the present invention can also be used in combination with hair growth substances such as Swertia japonica extract, carrot extract, capsicum tincture, ginger tincture, loquat leaf extract, glycyrrhetinic acid, dipotassium glycyrrhizinate, monoammonium glycyrrhizinate, pantothenic acid, panthenol, vitamin E and its derivatives, hinokitiol, salicylic acid, piroctone olamine, minoxidil, adenosine, t-flavanone, cytopurine, pentadecanoic acid glyceride, allantoin, and nicotinamide. By using the agent in combination, hair production is accelerated, and the effect of preventing or improving gray hair can be obtained at an early stage.

本発明のベルベルビンの誘導体、及びそれらの塩の配合量は、化粧品、医薬部外品、医薬品、飲食品又は試薬で提供する場合、それぞれ組成物全体に対して0.000001~20質量%、好ましくは0.0001~10質量%、より好ましくは0.01~1質量%である。 When the berberrubine derivatives and their salts of the present invention are provided as cosmetics, quasi-drugs, pharmaceuticals, food and beverages, or reagents, the blending amount of each is 0.000001 to 20% by mass, preferably 0.0001 to 10% by mass, and more preferably 0.01 to 1% by mass, based on the total composition.

また、本発明の白髪の予防又は改善剤、老人性脱毛症の予防又は改善剤、毛包構成細胞のDNA損傷抑制又は改善剤、及び色素幹細胞の減少抑制剤は、これを含む製品(医薬品、医薬部外品、飲食品、又は試薬等)又はその説明書に、白髪の予防又は改善、老人性脱毛症の予防又は改善、毛包構成細胞のDNA損傷抑制又は改善、毛包幹細胞のDNA損傷抑制又は改善、色素幹細胞のDNA損傷抑制又は改善、又は色素幹細胞の減少を抑制する作用を目的とするために用いられる旨の表示を付することができる。ここで、「製品またはその説明書に表示を付した」とは、製品の本体、容器、包装などに表示を付したこと、あるいは製品の情報を開示する説明書、添付文書、宣伝物、申請資料、その他の印刷物又は広告などに表示を付したことを意味する。また、これら表示においては、白髪の予防又は改善、老人性脱毛症の予防又は改善のために用いられることに関する情報、又は、毛包構成細胞のDNA損傷、毛包幹細胞のDNA損傷、色素幹細胞のDNA損傷、又は色素幹細胞の減少を抑制するに起因する疾患や症状の予防又は治療のために用いられることに関する情報を含むことができる。 In addition, the agent for preventing or improving gray hair, the agent for preventing or improving senile alopecia, the agent for inhibiting or improving DNA damage to hair follicle constituent cells, and the agent for inhibiting the decrease in melanocyte stem cells of the present invention can be labeled on a product (medicine, quasi-drug, food, beverage, reagent, etc.) containing the agent or its instructions to the effect of preventing or improving gray hair, preventing or improving senile alopecia, inhibiting or improving DNA damage to hair follicle constituent cells, inhibiting or improving DNA damage to hair follicle stem cells, inhibiting or improving DNA damage to melanocyte stem cells, or inhibiting the decrease in melanocyte stem cells. Here, "labeled on a product or its instructions" means that a label has been attached to the main body, container, packaging, etc. of the product, or that a label has been attached to instructions, package inserts, promotional materials, application documents, other printed matter, or advertisements disclosing information about the product. In addition, these labels can include information on the use for preventing or improving gray hair, preventing or improving senile alopecia, or information on the use for preventing or treating diseases or symptoms caused by DNA damage to hair follicle constituent cells, DNA damage to hair follicle stem cells, DNA damage to melanocyte stem cells, or inhibiting the decrease in melanocyte stem cells.

以下に実施例及び試験例を挙げ、本発明をさらに具体的に説明するが、本発明は実施例に限定されない。 The present invention will be explained in more detail below with reference to examples and test examples, but the present invention is not limited to these examples.

(試験例1)X線マウス白髪モデルを用いた抗白髪作用の評価
<試験方法>
生後7週齢のC57BL/6マウスに麻酔を施し、バリカンにて背部体毛を数mm残して刈り取った。毛刈り後、背部状態が良好な個体を選別し、各群の体重の平均値及び分散がほぼ等しくなるように層別無作為化割付(EXSUS Professional Version 7.7.1(CACエクシケア製)を使用)を行い、群分けした。
エタノールに0.1%(w/v)となるように塩化ベルベルビン又はベルベリン塩酸塩を溶解して調製した投与液、又は溶媒のエタノールを、毛刈り翌日よりマウスに1日1回200 μL、一週間塗布した。毛刈りより6日後に、麻酔下で背部の除毛を行った。除毛は、毛刈り部に除毛剤(エピラット(クラシエ製))を塗布することで行った。除毛の翌日に、X線照射装置(RX-650(Faxitron X-ray))により、マウスに総量5GyのX線を照射した。
体毛が生え揃うまで飼育した後、体毛に色彩色差計(CR-400(コニカミノルタ製))のプローブを当て、明度(L値)を測定し、白毛率の指標とした。
(Test Example 1) Evaluation of anti-hair graying effect using X-ray mouse gray hair model <Test method>
Seven-week-old C57BL/6 mice were anesthetized and the hair on their backs was shaved off with clippers, leaving a few millimeters. After shaving, mice with good back condition were selected and assigned to groups through stratified random allocation (using EXSUS Professional Version 7.7.1 (CAC Exicare)) so that the mean and variance of body weight in each group were approximately equal.
Berberubine chloride or berberine hydrochloride was dissolved in ethanol to a concentration of 0.1% (w/v), and the vehicle ethanol was applied to the mice once a day at 200 μL for one week, starting the day after hair shaving. Six days after hair shaving, hair removal was performed on the back under anesthesia. Hair removal was performed by applying a hair remover (Epilat (Kracie)) to the shaved area. The day after hair removal, the mice were irradiated with a total dose of 5 Gy of X-rays using an X-ray irradiator (RX-650 (Faxitron X-ray)).
After raising the mice until all the hair had grown in, the probe of a color difference meter (CR-400 (Konica Minolta)) was placed on the hair to measure the lightness (L value) and used as an index of the white hair rate.

<試験結果>
図1及び図2は、ベルベルビン及びベルベリンをそれぞれ評価した結果である。X線照射により、毛包幹細胞及び色素幹細胞にDNA損傷を与えると、色素幹細胞の減少により、体毛の明度が増加し、体毛の白色化が誘導された(非特許文献1)。しかし、ベルベルビン又はベルベリンの塗布により、体毛の明度の増加が抑制され、体毛の白色化が抑制された。つまり、ベルベルビン及びベルベリンに白髪予防及び改善作用が確認された。
これは、両化合物が、毛包幹細胞及び色素幹細胞のDNA損傷を抑制及び改善することで、毛包幹細胞の色素幹細胞ニッチ機能を維持及び改善し、これらの結果、色素幹細胞の異所性分化が抑制されて、色素幹細胞が維持されたと推察される(非特許文献1)。
つまり、両化合物は、DNA損傷の抑制及び改善作用、上皮系細胞の色素系細胞に対するニッチ機能の維持及び改善作用、色素幹細胞の異所性分化抑制作用及び維持作用を有することが推測される。
なお、ベルベルビン及びベルベリンに、X線の直接的な吸収・妨害作用がないことは確認済みである。
<Test Results>
Figures 1 and 2 show the results of evaluating berberrubin and berberine, respectively. When DNA damage was caused to hair follicle stem cells and melanocyte stem cells by X-ray irradiation, the number of melanocyte stem cells decreased, leading to an increase in hair brightness and induction of hair whitening (Non-Patent Document 1). However, application of berberrubin or berberine inhibited the increase in hair brightness and inhibited hair whitening. In other words, berberrubin and berberine were confirmed to have the effect of preventing and improving gray hair.
It is presumed that both compounds suppress and improve DNA damage in hair follicle stem cells and melanocyte stem cells, thereby maintaining and improving the melanocyte stem cell niche function of hair follicle stem cells, and as a result, ectopic differentiation of melanocyte stem cells is suppressed and melanocyte stem cells are maintained (Non-Patent Document 1).
In other words, both compounds are presumed to have the effects of inhibiting and improving DNA damage, maintaining and improving the niche function of epithelial cells for pigmentary cells, and inhibiting and maintaining ectopic differentiation of melanocyte stem cells.
It has been confirmed that berberrubine and berberine do not directly absorb or interfere with X-rays.

(試験例2)X線マウス老人性脱毛モデルを用いた抗脱毛作用の評価
X線は、加齢性の白髪以外に、加齢性の脱毛症(老人性脱毛症)と同様の機序で脱毛症を誘導できることが解明されている(非特許文献6)。老人性脱毛症は、男性ホルモンに起因する男性型脱毛症とは異なり、老化に伴う毛包幹細胞へのDNA損傷の蓄積が原因で、毛包幹細胞が徐々に失われて毛包のミニチュア化が起こる脱毛症であるが、X線を照射したマウスはこの老人性脱毛症モデルとしても用いることができる。
<試験方法>
生後7週齢のC57BL/6マウスに麻酔を施し、バリカンにて背部体毛を数mm残して刈り取った。毛刈り後、背部状態が良好な個体を選別し、各群の体重の平均値及び分散がほぼ等しくなるように層別無作為化割付(EXSUS Professional Version 7.7.1(CACエクシケア製)を使用)を行い、群分けした。
エタノールに0.1%(w/v)となるようにベルベリン塩酸塩を溶解して調製した投与液、又は溶媒のエタノールを、毛刈り翌日よりマウスに1日1回200 μL、一週間塗布した。毛刈りより6日後に、麻酔下で背部の除毛を行った。除毛は、毛刈り部に除毛剤(エピラット(クラシエ製))を塗布することで行った。除毛の翌日に、X線照射装置(RX-650(Faxitron X-ray))により、マウスに総量5GyのX線を照射した。
体毛の発生度合に差が見られる除毛後15日目及び17日目に、下記のスコア基準に従って発毛スコアを付け、発毛の程度を評価した。
(Test Example 2) Evaluation of anti-alopecia effect using X-ray mouse senile alopecia model It has been elucidated that X-ray can induce alopecia by the same mechanism as age-related alopecia (senile alopecia) in addition to age-related gray hair (Non-Patent Document 6).Senior alopecia is different from male pattern alopecia caused by male hormones, and is caused by the accumulation of DNA damage in hair follicle stem cells with aging, which gradually causes hair follicle stem cells to be lost, resulting in miniaturization of hair follicles.X-ray irradiated mice can also be used as this senile alopecia model.
<Test Method>
Seven-week-old C57BL/6 mice were anesthetized and the hair on their backs was shaved off with clippers, leaving a few millimeters. After shaving, mice with good back condition were selected and assigned to groups through stratified random allocation (using EXSUS Professional Version 7.7.1 (CAC Exicare)) so that the mean and variance of body weight in each group were approximately equal.
The administration solution, prepared by dissolving berberine hydrochloride in ethanol to a concentration of 0.1% (w/v), or the solvent ethanol was applied to the mice once a day at 200 μL for one week from the day after hair shaving. Six days after hair shaving, hair removal was performed on the back under anesthesia. Hair removal was performed by applying a hair remover (Epilat (Kracie)) to the shaved area. The day after hair removal, the mice were irradiated with a total dose of 5 Gy of X-rays using an X-ray irradiator (RX-650 (Faxitron X-ray)).
On the 15th and 17th days after hair removal, when differences in the degree of hair growth were observed, a hair growth score was given according to the following scoring criteria to evaluate the degree of hair growth.

スコア1:皮膚がピンク色を呈する
スコア2:皮膚が灰色に変色(剃毛部の30%未満)
スコア3:皮膚が灰色に変色(剃毛部の30%以上60%未満)あるいは毛の伸長が認められる(剃毛部の30%未満)
スコア4:皮膚が灰色に変色(剃毛部の60%以上)あるいは毛の伸長が認められる(剃毛部の30%以上60%未満)
スコア5:毛の伸長が認められる(剃毛部の60%以上)
Score 1: Pink skin Score 2: Gray skin (less than 30% of shaved area)
Score 3: Gray discoloration of the skin (30% to less than 60% of the shaved area) or hair growth (less than 30% of the shaved area)
Score 4: Gray discoloration of the skin (more than 60% of the shaved area) or hair growth (30% to less than 60% of the shaved area)
Score 5: Hair growth is observed (more than 60% of the shaved area)

<試験結果>
図3及び図4は、ベルベリンを評価した結果である。X線照射により、毛包幹細胞にDNA損傷を与えると、新生毛の発生が遅延した。しかし、ベルベリンの塗布により、新生毛の発生遅延が見られなくなった。つまり、ベルベリンに老人性脱毛症をはじめとする加齢に伴う脱毛の予防及び改善作用が確認された。
これは、ベルベリンが、毛包幹細胞のDNA損傷を抑制及び改善することで、毛包幹細胞が維持されたことによる。これらの作用は、試験例1の結果から、毛包幹細胞のDNA損傷抑制及び改善効果を有するベルベルビンも同様に有する。
<Test Results>
Figures 3 and 4 show the results of evaluating berberine. When DNA damage was caused to hair follicle stem cells by X-ray irradiation, the generation of new hair was delayed. However, the application of berberine eliminated the delay in the generation of new hair. In other words, berberine was confirmed to have the effect of preventing and improving hair loss associated with aging, including senile alopecia.
This is because berberine suppresses and improves DNA damage in hair follicle stem cells, thereby maintaining hair follicle stem cells. Based on the results of Test Example 1, berberrubin, which has the effect of suppressing and improving DNA damage in hair follicle stem cells, also has these actions.

本発明の白髪及び脱毛の予防又は改善剤は、加齢又はDNA損傷により生じる白髪及び脱毛の予防又は改善用の医薬部外品、医薬品又は飲食品の分野に利用可能である。また、毛包構成細胞のDNA損傷抑制又は改善剤、及び色素幹細胞の減少抑制剤もこれらの作用を必要とする医薬部外品、医薬品又は飲食品の分野に利用可能である。 The agent for preventing or improving gray hair and hair loss of the present invention can be used in the fields of quasi-drugs, medicines, or food and beverage products for preventing or improving gray hair and hair loss caused by aging or DNA damage. In addition, the agent for inhibiting or improving DNA damage in hair follicle constituent cells and the agent for inhibiting the decrease in melanocyte stem cells can also be used in the fields of quasi-drugs, medicines, or food and beverage products that require these effects.

Claims (5)

ベルベルビン及びその塩からなる群から選択される少なくとも1種を有効成分とする、白髪の予防又は改善剤(但し、オウレン抽出物を含む白髪の予防又は改善剤、及びオウバク又はオウバク抽出物を含む白髪の予防又は改善剤を除く)。 An agent for preventing or improving gray hair, comprising at least one active ingredient selected from the group consisting of berberrubine and its salts (however, excluding agents for preventing or improving gray hair containing a Coptis japonica extract and agents for preventing or improving gray hair containing Phellodendron Bark or Phellodendron Bark extract ). ベルベルビン、ベルベリン、及びこれらの塩からなる群から選択される少なくとも1種を有効成分とする、老人性脱毛症の予防又は改善剤(但し、オウレン抽出物を含む老人性脱毛症の予防又は改善剤、及びオウバク又はオウバク抽出物を含む老人性脱毛症の予防又は改善剤を除く)。 An agent for preventing or improving senile alopecia, comprising at least one active ingredient selected from the group consisting of berberrubine, berberine, and salts thereof (excluding, however, an agent for preventing or improving senile alopecia containing a Coptis japonica extract , and an agent for preventing or improving senile alopecia containing Phellodendron Bark or an extract of Phellodendron Bark ). ベルベルビン、ベルベリン、及びこれらの塩からなる群から選択される少なくとも1種を有効成分とする、毛包構成細胞のDNA損傷抑制又は改善剤(但し、オウレン抽出物を含む
毛包構成細胞のDNA損傷抑制又は改善剤、及びオウバク又はオウバク抽出物を含む毛包構成細胞のDNA損傷抑制又は改善剤を除く)。
An agent for suppressing or improving DNA damage in hair follicle constituent cells, comprising at least one active ingredient selected from the group consisting of berberrubine, berberine, and salts thereof (excluding agents for suppressing or improving DNA damage in hair follicle constituent cells containing Coptis japonica extract , and agents for suppressing or improving DNA damage in hair follicle constituent cells containing Phellodendron Bark or Phellodendron Bark extract ).
毛包構成細胞が、毛包幹細胞又は色素幹細胞である、請求項3に記載のDNA損傷抑制又は
改善剤。
The agent for suppressing or ameliorating DNA damage according to claim 3 , wherein the hair follicle constituent cells are hair follicle stem cells or melanocyte stem cells.
ベルベルビン、ベルベリン、及びこれらの塩からなる群から選択される少なくとも1種を有効成分とする、色素幹細胞の減少抑制剤(但し、オウレン抽出物を含む色素幹細胞の減少抑制剤、及びオウバク又はオウバク抽出物を含む色素幹細胞の減少抑制剤を除く)。 An inhibitor of the decrease in melanocyte stem cells, comprising at least one active ingredient selected from the group consisting of berberrubine, berberine, and salts thereof (excluding inhibitors of the decrease in melanocyte stem cells containing a coptis japonica extract and inhibitors of the decrease in melanocyte stem cells containing Phellodendron Bark or an extract of Phellodendron Bark ).
JP2020101481A 2019-06-26 2020-06-11 Hair Anti-Aging Agent Active JP7630764B2 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2019118073 2019-06-26
JP2019118073 2019-06-26

Publications (2)

Publication Number Publication Date
JP2021004235A JP2021004235A (en) 2021-01-14
JP7630764B2 true JP7630764B2 (en) 2025-02-18

Family

ID=74097513

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2020101481A Active JP7630764B2 (en) 2019-06-26 2020-06-11 Hair Anti-Aging Agent

Country Status (1)

Country Link
JP (1) JP7630764B2 (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN117482088A (en) * 2023-10-30 2024-02-02 复旦大学附属华山医院 Application of berberine in the preparation of drugs for treating hair loss

Citations (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2009507012A (en) 2005-09-06 2009-02-19 セデルマ Use of protoberberine as an active substance that regulates the activity of the pilosebaceous unit
CN101596252A (en) 2009-07-14 2009-12-09 王婷 A kind of composition and method of making the same for the treatment of herpes zoster
CN102058825A (en) 2009-11-17 2011-05-18 深圳同安药业有限公司 Traditional Chinese medicinal composition for treating hepatitis and preparation method thereof
JP2016121135A (en) 2014-12-25 2016-07-07 大正製薬株式会社 Hair improving agent
WO2017138652A1 (en) 2016-02-12 2017-08-17 花王株式会社 Melanin decomposition inhibitor
CN107095993A (en) 2017-06-19 2017-08-29 马绪梅 A kind of Chinese medicine for treating Respiratory Medicine bronchopulmonary aspergillosis
JP2018043951A (en) 2016-09-15 2018-03-22 株式会社ツムラ Method for producing berberine type alkaloid
JP2018168166A (en) 2016-01-12 2018-11-01 国立大学法人 東京医科歯科大学 Composition for suppressing or improving hair loss and whitening and use thereof
JP2019031482A (en) 2017-08-04 2019-02-28 大正製薬株式会社 Pigment cell activator, scf production promoter, and vegf production promoter
JP2019052145A (en) 2017-09-13 2019-04-04 大正製薬株式会社 Composition for controlling the production of various factors containing mitol production-promoting component as active ingredient, mitol production promoter, and method for screening agent for controlling the production of various factors with mitol production-promoting action as index
JP2020152711A (en) 2019-03-21 2020-09-24 キム,ムンキュ Shampoo composition for improving scalp and hair conditions

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH0578222A (en) * 1991-05-01 1993-03-30 Sansho Seiyaku Co Ltd Preventive for gray hair
JPH10298055A (en) * 1997-04-22 1998-11-10 Noevir Co Ltd Antiandrogenic agent, hair tonic and sebum secretion suppressor
JPH1160449A (en) * 1997-08-26 1999-03-02 Sunstar Inc Hair tonic composition
KR20160027372A (en) * 2014-08-29 2016-03-10 김윤정 Therapeutic composition for alopecia

Patent Citations (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2009507012A (en) 2005-09-06 2009-02-19 セデルマ Use of protoberberine as an active substance that regulates the activity of the pilosebaceous unit
CN101596252A (en) 2009-07-14 2009-12-09 王婷 A kind of composition and method of making the same for the treatment of herpes zoster
CN102058825A (en) 2009-11-17 2011-05-18 深圳同安药业有限公司 Traditional Chinese medicinal composition for treating hepatitis and preparation method thereof
JP2016121135A (en) 2014-12-25 2016-07-07 大正製薬株式会社 Hair improving agent
JP2018168166A (en) 2016-01-12 2018-11-01 国立大学法人 東京医科歯科大学 Composition for suppressing or improving hair loss and whitening and use thereof
WO2017138652A1 (en) 2016-02-12 2017-08-17 花王株式会社 Melanin decomposition inhibitor
JP2018043951A (en) 2016-09-15 2018-03-22 株式会社ツムラ Method for producing berberine type alkaloid
CN107095993A (en) 2017-06-19 2017-08-29 马绪梅 A kind of Chinese medicine for treating Respiratory Medicine bronchopulmonary aspergillosis
JP2019031482A (en) 2017-08-04 2019-02-28 大正製薬株式会社 Pigment cell activator, scf production promoter, and vegf production promoter
JP2019052145A (en) 2017-09-13 2019-04-04 大正製薬株式会社 Composition for controlling the production of various factors containing mitol production-promoting component as active ingredient, mitol production promoter, and method for screening agent for controlling the production of various factors with mitol production-promoting action as index
JP2020152711A (en) 2019-03-21 2020-09-24 キム,ムンキュ Shampoo composition for improving scalp and hair conditions

Also Published As

Publication number Publication date
JP2021004235A (en) 2021-01-14

Similar Documents

Publication Publication Date Title
JP6225228B2 (en) Compound with wrinkle-improving effect
EP3288531B1 (en) Method of improving skin health and compositions therefor
CN114096233A (en) Combination of biological energy and methods of using same
EP3210613A1 (en) Composition for external application
JP2020502082A (en) Cosmetic blend
JP5787285B2 (en) Fibroblast proliferation promoter, keratinocyte migration / proliferation promoter, elastin production promoter, heat shock protein 47 production promoter, α-smooth muscle actin (α-SMA) production promoter, and photoaging inhibitor.
US20180311142A1 (en) Composition for treating skin pigmentation and related methods
JP2015178485A (en) Hair restoration composition
JP2008156330A (en) Activating agent and anti-aging agent
Saewan et al. Anti-aging efficacy of Thai red rice callus cosmetic product
JP7630764B2 (en) Hair Anti-Aging Agent
JP4939766B2 (en) Basement membrane stabilizer
JP2006282597A (en) Hair papilla cell growth promoter, vascular endothelial growth factor (vegf) production promoter and hair-restoring or growing agent
BR112015030331B1 (en) SUCCINATE DERIVATIVES, THEIR USES, COSMETIC OR PHARMACEUTICAL COMPOSITION, COSMETIC METHODS, AND PROCESS TO PREPARE A CREAM
JP2014129267A (en) DNA damage inhibitor
JP5216228B2 (en) Extracellular matrix production improver
US20070243146A1 (en) Vitamin K1 as Energizer in Cosmetic Formulations
JP2017031108A (en) Anti-wrinkle agent, collagen production promoter, mmp-1 production inhibitor, and elastase activity inhibitor that contain urolithin
JP2014122183A (en) Dna damage inhibitor
JP2008239548A (en) Cell activator
CN115400129A (en) Composition for changing cell aging phenotype or preventing skin aging
CN109562046A (en) Cosmetic composition containing sclareolide
JP2017112918A (en) Screening method for subcutaneous tissue structure improvement component
JP6690220B2 (en) Agent for hair
JP2014125429A (en) Dna damage inhibitor

Legal Events

Date Code Title Description
A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20230530

RD03 Notification of appointment of power of attorney

Free format text: JAPANESE INTERMEDIATE CODE: A7423

Effective date: 20240308

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20240708

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20240809

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20241025

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20241202

TRDD Decision of grant or rejection written
A01 Written decision to grant a patent or to grant a registration (utility model)

Free format text: JAPANESE INTERMEDIATE CODE: A01

Effective date: 20250106

A61 First payment of annual fees (during grant procedure)

Free format text: JAPANESE INTERMEDIATE CODE: A61

Effective date: 20250119

R150 Certificate of patent or registration of utility model

Ref document number: 7630764

Country of ref document: JP

Free format text: JAPANESE INTERMEDIATE CODE: R150